Direct monitoring of organic reactions on polymeric supports

Tetrahedron Letters

Volumn 38, Issue 36, 1997, Pages 6331-6334

  Carrasco, Michael R ^a,b   Fitzgerald, Michael C ^a   Oda, Yoshiya ^a,c   Kent, Stephen B H ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Gryphon Therapeutics   (United States)

^c EISAI CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ORGANIC COMPOUND;

ARTICLE; DRUG SYNTHESIS; LASER; MASS SPECTROMETRY; MONITORING; PROTEIN SYNTHESIS; TECHNIQUE;

EID: 0030764736     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(97)01456-1     Document Type: Article

References (40)

1. a) Merrifield, R. B. J. Am. Chem. Soc. 1963, 85, 2149-2154.
2. b) Lloyd-Williams, P.; Albericio, F.; Giralt, E. Tetrahedron 1993, 49, 11065-11133.
3. Leznoff, C. C. Acc. Chem. Res. 1978, 11, 327-333.
4. Beaucage, S. L.; Iyer, R. P. Tetrahedron 1992, 48, 2223-2311.
5. Yan, L.; Taylor, C. M.; Goodnow Jr., R.; Kahne, D. J. Am. Chem. Soc. 1994, 116, 6953-6954.
6. a) Chen, C.; Ahlberg Randall, L. A.; Miller, R. B.; Jones, A. D.; Kurth, M. J. J. Am. Chem. Soc. 1994, 116, 2661-2662.
7. b) DeWitt, S. H.; Czarnik, A. W. Acc. Chem. Res. 1996, 29, 114-122.
8. Ellman, J. A. Acc. Chem. Res. 1996, 29, 132-143.
9. Gordon, E. M.; Gallop, M. A.; Patel, D. V. Acc. Chem. Res. 1996,29, 144-154.
10. a) Blossey, E. C.; Cannon, R. G.; Ford, W. T.; Periyasamy, M.; Mohanraj, S. J. Org. Chem. 1990, 55, 4664-4668.
11. b) Fitch, W. L.; Detre, G.; Holmes, C. P.; Shoolery, J. N.; Keifer, P. A. J. Org. Chem. 1994, 59, 7955-7956.
12. c) Look, G. C.; Holmes, C. P.; Chinn, J. P.; Gallop, M. A. J. Org. Chem. 1994, 59, 7588-7590.
13. d) Anderson, R. C.; Jarema, M. A.; Shapiro, M. J.; Stokes, J. P.; Ziliox, M. J. Org. Chem. 1995, 60, 2650-2651.
14. e) Garigipati, R. S.; Adams, B.; Adams, J. L.; Sarkar, S. K. J. Org. Chem. 1996,67, 2911-2914.
15. a) Crowley, J. I.; Rapoport, H. J. Org. Chem. 1980, 45, 3215-3227.
16. b) Van, B.; Kumaravel, G.; Anjaria, H.; Wu, A.; Petter, R. C.; Jewell Jr., C. F.; Wareing, J. R. J. Org. Chem. 1995, 60, 5736-5738.
17. c) Gosselin, F.; Di Renzo, M.; Ellis, T. H.; Lubell, W. D. J. Org. Chem. 1996, 61, 7980-7981.
18. d) Russell, K.; Cole, D. C.; McLaren, F. M.; Pivonka, D. E. J. Am. Chem. Soc. 1996, 118, 7941-7945.
19. a) van Veelen, P. A.; Tjaden, U. R.; van der Greef, J. Rapid Commun. Mass Spectrom. 1991, 5, 565-568.
20. b) Brummel, C. L.; Lee, I. N. W.; Zhou, Y.; Benkovic, S. J.; Winograd, N. Science 1994, 264, 399-402.
21. c) Stanková, M.; Issakova, O.; Sepetov, N. F.; Krchnák, V.; Lam, K. S.; Lebl, M. Drug Dev. Res. 1994, 33, 146-156.
22. d) Zambias, R. A.; Boulton, D. A.; Griffin, P. R. Tetrahedron Lett. 1994, 4283-4286.
23. e) Brown, B. B.; Wagner, D. S.; Geysen, H. M. Molecular Diversity 1995, 1, 4-12.
24. f) Egner, B. J.; Langley, G. J.; Bradley, M. J. Org. Chem. 1995, 60, 2652-2653.
25. g) Haskins, N. J.; Hunter, D. J.; Organ, A. J.; Rahman, S. S.; Thom, C. Rapid Commun. Mass Spectrom. 1995, 9, 1437-1440.
26. h) Drouot, C.; Enjaibal, C.; Fulcrand, P.; Martinez, J.; Aubagnac, J.-L.; Combarieu, R.; de Puydt, Y. Rapid Commun. Mass Spectrom. 1996, 10, 1509-1511.
27. i) Ching, J.; Voivodov, K. I.; Hutchens, T. W. Bioconj. Chem. 1996, 7, 525-528.
28. Fitzgerald, M. C.; Harris, K. H.; Shevlin, C. G.; Siuzdak, G. Bioorg. Med. Chem. Lett. 1996, 6, 979-982.
29. Tam, J. P.; Tjoeng, F. S.; Merrifield, R. B. J. Am. Chem. Soc. 1980, 102, 6117-6127.
30. a) Bartlet-Jones, M.; Jeffery, W. A.; Hansen, H. F.; Pappin, D. J. C. Rapid Commun. Mass Spectrom. 1994, 8, 737-742.
31. b) Liao, P. C.; Allison, J. J. Mass Spectrom. 1995, 30, 511-512.
32. 12a and appropriate commercially available reagents. As noted, the modular strategy allows for various procedures to create equally functional constructs.
33. Rich, D. H.; Gurwara, S. K. Tetrahedron Lett. 1975, 301-304.
34. Schnölzer, M.; Alewood, P.; Jones, A.; Alewood, D.; Kent, S. B. H. Int. J. Pept. Protein Res. 1992, 40, 180-193.
35. 10
36. Chou, J. Z.; Kreek, M. J.; Chait, B. T. J. Am. Soc. Mass Spectrom. 1994, 5, 10-16.
37. All MALDI mass spectra were generated on a Ciphergen Biosystems Massphoresis System time-of-flight mass spectrometer. Typical resolution (m/Δm, where Δm = full width at half maximum) for these samples on this instrument was 100-200. All spectra were calibrated internally on matrix peaks.
38. + for any given substrate. Separate solution photolyses (354 nm, DMF, 1h) followed by ESI-MS analysis, along with other experiments, have indicated that these peaks are an artifact of the MALDI process. Our experiments have also shown that the extent of adduct formation is highly dependent on a combination of factors including the chemical nature of the substrate and photocleavable link as well as the MALDI matrix used.
39. a) Heck, R. F. Acc. Chem. Res., 1979, 12, 146-151.
40. b) Yu, K.-L.; Deshpande, M. S.; Vyas, D. M. Tetrahedron Lett. 1994, 35, 8919-8922.